StonvexLoading…
StonvexStonvexStonvexCore line items from WTS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.44B | $2.25B | $2.06B | $1.98B |
Operating Income | $448.10M | $390.40M | $350.90M | $315.00M |
Net Income | $340.80M | $291.20M | $262.10M | $251.50M |
EPS (Diluted) | $10.17 | $8.69 | $7.82 | $7.48 |
Total Assets | $2.88B | $2.40B | $2.31B | $1.93B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $405.50M | $386.90M | $350.10M | $310.80M |
Free Cash Flow OCF − CapEx | $356.30M | $325.80M | $281.10M | $195.90M |
Shares Outstanding | 33.50M | 33.50M | 33.50M | 33.60M |